
Fulcrum Therapeutics, Inc. / Insider Transactions
Source | Name | Title | Transaction Date | Shares | Price | Value |
|
---|---|---|---|---|---|---|---|
| Tourangeau Greg | Principal Accounting Officer |
|
|
|
| |
| Tourangeau Greg | Principal Accounting Officer |
|
|
|
| |
| Tourangeau Greg | Vice President, Finance |
|
|
|
| |
| Sapir Alex | See Remarks |
|
|
|
| |
| Tourangeau Greg | Principal Accounting Officer |
|
|
|
| |
| Shah Rajeev M. | N/A |
|
|
|
| |
| Gould Robert J | Interim President & CEO |
|
|
|
| |
| Shah Rajeev M. | N/A |
|
|
|
| |
| Shah Rajeev M. | N/A |
|
|
|
| |
| Shah Rajeev M. | N/A |
|
|
|
| |
| Shah Rajeev M. | N/A |
|
|
|
| |
| GERAGHTY JAMES A | N/A |
|
|
|
| |
| Morabito Christopher | Chief Medical Officer |
|
|
|
| |
| Oltmans Curtis Gale | SVP, General Counsel |
|
|
|
| |
| Thomson Peter G. | VP Finance & Accounting |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Thomson Peter G. | VP Finance & Accounting |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Wallace Owen B. | Chief Scientific Officer |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Cadavid Diego | SVP Clinical Development |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Thomson Peter G. | VP Finance & Accounting |
|
|
|
| |
| Cadavid Diego | SVP Clinical Development |
|
|
|
| |
| Thomson Peter G. | VP Finance & Accounting |
|
|
|
| |
| Gould Robert J | See Remarks |
|
|
|
| |
| Cadavid Diego | SVP Clinical Development |
|
|
|
| |
| Thomson Peter G. | VP Finance & Accounting |
|
|
|
| |
| 6 Dimensions Capital, L.P. | N/A |
|
|
|
| |
| Casdin Eli | N/A |
|
|
|
| |
| LEVIN MARK J | N/A |
|
|
|
| |
| Sanofi | N/A |
|
|
|
| |
| TEPPER ROBERT I | N/A |
|
|
|
| |
| TRV GP IV, LLC | N/A |
|
|
|
|